American Virtual Cloud Technologies (AVCT) – Press Releases
-
AVC Technologies Announces Receipt of Unsolicited Non-Binding Acquisition Proposal and Exploration of Strategic Alternatives
-
AVC Technologies Announces Receipt of Unsolicited Non-Binding Acquisition Proposal and Exploration of Strategic Alternatives
-
AVCtechnologies Hires Chief Growth Officer to Accelerate Business Opportunities
-
AVCtechnologies Hires Chief Growth Officer to Accelerate Business Opportunities
-
Avacta Announces Distribution Agreement With ABCAM plc
-
AVCtechnologies Named Growth Partner of the Year by AT&T Cybersecurity
-
AVCtechnologies Named Growth Partner of the Year by AT&T Cybersecurity
-
Computex Technology Solutions Named Largest Houston-Area Cybersecurity Company By Houston Business Journal For Second Year In A Row
-
Orion Innovation Announces Strategic Partnerships with Ribbon Communications and American Virtual Cloud Technologies for Digital Product Development Services
-
Avacta’s Rapid Antigen Test Is Confirmed to Detect SARS-CoV-2 New Variants
-
AVC Technologies Appoints Carolyn Byrd to the Board of Directors
-
AVC Technologies Appoints Carolyn Byrd to the Board of Directors
-
Computex Named to the 2021 Elite 150 in CRN® MSP 500 List
-
Avacta Announces Phase 1 Clinical Trial Authorisation (CTA) for AVA6000 Approved by MHRA
-
Avacta and Mologic Announce Commercial Partnership
-
Avacta announces AffyXell $7.3 Million Series A Financing
-
Avacta Announces Collaboration Agreement With Bruker
-
Navigation Capital Partners SPAC Operations Significantly Expands SPAC Portfolio
-
Avacta Announces License Agreement With POINT Biopharma Inc.
-
Avacta Submits Clinical Trial Application for AVA6000 pro-doxorubixin
-
Avacta Group plc Signs License Agreement With Astrea Bioseparations
-
AVCT Announces Michael Dennis as New COO
-
AVCT Announces Michael Dennis as New COO
-
AVCtechnologies Completes Strategic Acquisition of Ribbon's Kandy Communications
-
Avacta Launches SARS-CoV-2 BAMS Research Test
-
AVCT Announces Xavier Williams as New CEO
-
AVCT Announces Xavier Williams as New CEO
-
Avacta Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity
-
Avacta and LG Chem Life Sciences Expand Partnership
-
Avacta Appoints Therapeutics Chief Development Officer
-
Avacta Announces SARS-CoV-2 Rapid Antigen Test Clinical Collaboration
-
Avacta Appoints COVID-19 Rapid Antigen Test Manufacturing Partner
-
AVCtechnologies Announces Agreement to Buy Ribbon's Kandy Communications Business
-
Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy
-
Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test
-
Avacta and Integumen plc collaborate for detection of SARS-COV-2 coronavirus in waste water
-
AVC Technologies Appoints Kent Mathy to the Board of Directors
-
AVC Technologies Appoints Kent Mathy to the Board of Directors
-
Avacta Provides Update on COVID-19 Rapid Antigen Test Development Partnership With Cytiva
-
Avacta provides update on Affimer therapy for COVID-19 infection
-
Avacta Provides Update on COVID-19 Antigen Diagnostic Test Development With Adeptrix
-
Avacta and Medusa19 Enter Into a Distribution Agreement For COVID-19 Antigen Test
-
Avacta Develops SARS-COV-2 Neutralising Affimer Reagents with Therapeutic Potential for COVID-19
-
AVCT Fuels Next Stage of Growth With Executive Hire & Computex Realignment
-
AVCT Fuels Next Stage of Growth With Executive Hire & Computex Realignment
-
Avacta Ships SARS-COV-2 Affimer Reagents to Cytiva and Adeptrix
-
Avacta Group plc Forms COVID-19 Antigen Diagnostic Collaboration With Adeptrix
-
Navigation Capital Partners’ Portfolio Company Computex Sold to American Virtual Cloud Technologies
-
Avacta Successfully Generates Several Highly Specific Affimer Reagents for COVID-19 Antigen Rapid Test Ahead of Schedule as Part of Cytiva Partnership
-
Avacta and Cytiva Collaborating on COVID-19 Rapid Test
Back to AVCT Stock Lookup
